Zinc supplementation for epidermal growth factor receptor inhibitors induced skin toxicity

J Am Acad Dermatol. 2024 Sep;91(3):e69-e71. doi: 10.1016/j.jaad.2024.04.070. Epub 2024 May 10.

Authors

Youssef El-Sayes¹, Maxine Joly-Chevrier², Hessah BinJadeed³, Ivan V Litvinov³, Elena Netchiporouk⁴

Affiliations

¹ Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
² Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
³ Division of Dermatology, McGill University, Montreal, Quebec, Canada.
⁴ Division of Dermatology, McGill University, Montreal, Quebec, Canada. Electronic address: [email protected].

PMID: 38734240
DOI: 10.1016/j.jaad.2024.04.070

No abstract available

Keywords: EGFRI; cancer; medical dermatology; oncology; zinc; zinc supplementation.

Publication types

Letter
Case Reports

MeSH terms

Aged
Antineoplastic Agents / adverse effects
Dietary Supplements / adverse effects
Drug Eruptions / etiology
ErbB Receptors* / antagonists & inhibitors
Female
Humans
Male
Middle Aged
Zinc* / adverse effects

Substances

ErbB Receptors
Zinc
Antineoplastic Agents